Last checked at 8 Jul 2014 11:22
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Proteome Share News (PRM)
PRM Share
Price
PRM Share
News
PRM Share
Chat
PRM Share
Trades
PRM
Live RNS
PRM Share
Charts
PRM Level 2
Console
PRM Live
Share Price
PRM Broker
Ratings
PRM Directors
Deals
PRM Financial
Diary
PRM
Fundamentals
PRM Short
Positions
PRM
Media
Proteome Information
Share Price Information for Proteome (PRM)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
3.51
Bid:
3.02
Ask:
4.00
Change:
0.00 (0.00%)
Spread:
0.98 (32.45%)
Open:
3.51
High:
0.00
Low:
0.00
Prev. Close:
3.51
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Proteome punished as sales fail to perk up
Tue, 24th Jul 2018 08:04
(Sharecast News) - Proteome Sciences trimmed losses in the first half as the protein biomarker specialist cut costs and revenues stalled.Total revenues of £1.32m for the six-month period ended 30 June were down 2.4% on the period the previous year, as the company said the uptake in sales was "slower than anticipated" , but the firm's loss before tax was still slashed by 22% to £1.41m.Proteome managed to cut administrative costs by 18% to £2.02m after a laboratory consolidation in Frankfurt and office relocation to Central London pushed last year's figures up.As at 30 June the group had cash resources of £0.50m, down from £0.87m in 2017.Chief executive Jeremy Haigh said: "Performance during the first six months of 2018 was behind expectations, with recognised revenues from our services business still lagging committed work orders as we continue to build our customer base; TMT revenues were ahead of the equivalent period in 2017."Haigh added that interest in Europe and the US had grown after a marketing campaign and Proteome's attendance to a variety of international conferences and conventions.In total, the company secured 16 service orders with a total value of £0.49m in the period, outstripping the comparative period in 2017."We continue to broaden the range of our proteomic services and are optimistic that these, combined with our commitment to reliability, cost and quality, will allow us to develop our presence in an important and expanding market. As in previous years, we expect a stronger second half with further progress," said Haigh.Proteome Sciences' shares were down 8.08% at 3.47p at 0819 BST.
More News
8 Jul 2014 11:19
8 Jul 2014 08:45
UPDATE 1-Study paves way for simple blood test to predict Alzheimer's
* Fatal brain-wasting disease has no effective treatments * Experts say drug failures may be due to late trials * Predictive test could find people before disease sets in * Shares in Proteome Sciences, involved in work, jump 12 pct (Adds Proteome Sciences stock move) By
Read more29 May 2014 10:22
Proteome Sciences Confident For Revenue Growth As Loss Narrows
LONDON (Alliance News) - Proteome Sciences PLC Thursday expressed confidence for continued fast revenue growth for the "forseeable future", as it posted a narrowed pretax loss for 2013, driven by strong sales of its Tandem Mass Tag reagents and growth in its biomarker assays. Proteome is en
Read more27 Mar 2014 14:08
Proteome Says Study Using SysQuant Technology Demonstrates Its Potential
LONDON (Alliance News) - Proteome Sciences PLC said Thursday that a study using its SysQuant technology to address pancreatic cancer published in medical journal PLOS ONE demonstrated the potential of proteomics to improve the way that bespoke treatments can be made to match patients. Prote
Read more28 Feb 2014 16:18
XP Power board members reduce holdings
XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t
Read more24 Feb 2014 10:48
Proteome Sciences To Raise GBP5 Million In Share Placing
LONDON (Alliance News) - Proteome Sciences PLC said Monday it has placed 17.9 million new shares on the market to raise GBP5 million before expenses, with new and existing investors, which it will use for additional working capital. The protein biomarker company said the shares were placed
Read more7 Feb 2014 10:06
Proteome edges ahead after flagging rise in revenue
Biotech group Proteome Sciences edged ahead after it revealed it expects revenue for 2013 to show "a significant increase" over 2012 thanks to strong performance across its core activities. The firm is an expert in biomarkers, or biological markers, that can help predict the likelihood of cancer r
Read more7 Feb 2014 09:08
Proteome Sciences Says 2013 Revenues To Be Significantly Up
LONDON (Alliance News) - Shares in Proteome Sciences PLC rose in early trading Friday, after the protein biomarker company said revenue for 2013 will be significantly higher than the prior year, driven by a strong performance from all its core activities. Proteome is engaged in research an
Read more4 Dec 2013 10:39
Proteome Sciences unveils sales delays, shares fall
Biotechnology group Proteome Sciences is facing sales delays that will push revenue from some deals into next year, hitting its shares. Proteome, which carries out research into protein and peptide biomarkers to treat neurological conditions and other illnesses such as cancer, said the timing and r
Read more20 Nov 2013 07:52